Cargando…
Antidepressant Adherence Among Hispanics: Patients in an Integrated Health Care Model
PURPOSE: We report on antidepressant (AD) adherence among Hispanics seeking mental health services in a community primary care clinic in Texas as an ancillary outcome from a National Institutes of Health-funded study that collected data on Hispanic AD adherence over a period of two years (February 2...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809177/ https://www.ncbi.nlm.nih.gov/pubmed/36605408 http://dx.doi.org/10.2147/JMDH.S387218 |
_version_ | 1784863069119184896 |
---|---|
author | Kunz-Lomelin, Alan Killian, Michael Eghaneyan, Brittany H Sanchez, Katherine |
author_facet | Kunz-Lomelin, Alan Killian, Michael Eghaneyan, Brittany H Sanchez, Katherine |
author_sort | Kunz-Lomelin, Alan |
collection | PubMed |
description | PURPOSE: We report on antidepressant (AD) adherence among Hispanics seeking mental health services in a community primary care clinic in Texas as an ancillary outcome from a National Institutes of Health-funded study that collected data on Hispanic AD adherence over a period of two years (February 2016–February 2018). Adherence to AD medications was measured throughout the year-long trial and compared across various demographic characteristics. Since Hispanic individuals often experience stigma and cultural barriers related to AD treatment, we sought to understand what factors may increase the likelihood of non-adherence in this population. PATIENTS AND METHODS: This study focused on 69 patients who were prescribed AD medications while receiving treatment through an integrated health care model. Adherence was measured with the Patient Adherence Questionnaire, a validated 2-item questionnaire that asks patients about their medication use (missed medications or dosage changes) over the past week. We looked at patient adherence at two key time points (4-weeks and 13-weeks) and utilized logistic regression to identify factors that may increase or decrease the likelihood of adherence in Hispanic patients at a community primary care clinic. RESULTS: Non-adherence to AD medication was 49.3% at 4-weeks and 57% at 13-weeks post-treatment initiation. Logistic regression analyses revealed that age was the only significant predictor of AD non-adherence. As age increased, the likelihood of adherence increased by 12.2% at 13-weeks post-treatment initiation and by 11.1% at 4-weeks post-treatment initiation. CONCLUSION: The likelihood of Hispanic patients to adhere to AD therapy increased with the age of the patient. Since primary care is the most likely place to be prescribed an AD for Hispanic patients, further research to better understand adherence is essential. Integrated health care interventions designed to help identify, reduce, or eliminate barriers to adherence and improve cultural understanding may help address issues of non-adherence in primary care settings. |
format | Online Article Text |
id | pubmed-9809177 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-98091772023-01-04 Antidepressant Adherence Among Hispanics: Patients in an Integrated Health Care Model Kunz-Lomelin, Alan Killian, Michael Eghaneyan, Brittany H Sanchez, Katherine J Multidiscip Healthc Original Research PURPOSE: We report on antidepressant (AD) adherence among Hispanics seeking mental health services in a community primary care clinic in Texas as an ancillary outcome from a National Institutes of Health-funded study that collected data on Hispanic AD adherence over a period of two years (February 2016–February 2018). Adherence to AD medications was measured throughout the year-long trial and compared across various demographic characteristics. Since Hispanic individuals often experience stigma and cultural barriers related to AD treatment, we sought to understand what factors may increase the likelihood of non-adherence in this population. PATIENTS AND METHODS: This study focused on 69 patients who were prescribed AD medications while receiving treatment through an integrated health care model. Adherence was measured with the Patient Adherence Questionnaire, a validated 2-item questionnaire that asks patients about their medication use (missed medications or dosage changes) over the past week. We looked at patient adherence at two key time points (4-weeks and 13-weeks) and utilized logistic regression to identify factors that may increase or decrease the likelihood of adherence in Hispanic patients at a community primary care clinic. RESULTS: Non-adherence to AD medication was 49.3% at 4-weeks and 57% at 13-weeks post-treatment initiation. Logistic regression analyses revealed that age was the only significant predictor of AD non-adherence. As age increased, the likelihood of adherence increased by 12.2% at 13-weeks post-treatment initiation and by 11.1% at 4-weeks post-treatment initiation. CONCLUSION: The likelihood of Hispanic patients to adhere to AD therapy increased with the age of the patient. Since primary care is the most likely place to be prescribed an AD for Hispanic patients, further research to better understand adherence is essential. Integrated health care interventions designed to help identify, reduce, or eliminate barriers to adherence and improve cultural understanding may help address issues of non-adherence in primary care settings. Dove 2022-12-30 /pmc/articles/PMC9809177/ /pubmed/36605408 http://dx.doi.org/10.2147/JMDH.S387218 Text en © 2022 Kunz-Lomelin et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Kunz-Lomelin, Alan Killian, Michael Eghaneyan, Brittany H Sanchez, Katherine Antidepressant Adherence Among Hispanics: Patients in an Integrated Health Care Model |
title | Antidepressant Adherence Among Hispanics: Patients in an Integrated Health Care Model |
title_full | Antidepressant Adherence Among Hispanics: Patients in an Integrated Health Care Model |
title_fullStr | Antidepressant Adherence Among Hispanics: Patients in an Integrated Health Care Model |
title_full_unstemmed | Antidepressant Adherence Among Hispanics: Patients in an Integrated Health Care Model |
title_short | Antidepressant Adherence Among Hispanics: Patients in an Integrated Health Care Model |
title_sort | antidepressant adherence among hispanics: patients in an integrated health care model |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809177/ https://www.ncbi.nlm.nih.gov/pubmed/36605408 http://dx.doi.org/10.2147/JMDH.S387218 |
work_keys_str_mv | AT kunzlomelinalan antidepressantadherenceamonghispanicspatientsinanintegratedhealthcaremodel AT killianmichael antidepressantadherenceamonghispanicspatientsinanintegratedhealthcaremodel AT eghaneyanbrittanyh antidepressantadherenceamonghispanicspatientsinanintegratedhealthcaremodel AT sanchezkatherine antidepressantadherenceamonghispanicspatientsinanintegratedhealthcaremodel |